The Annual Meeting of Stockholders (the “Annual Meeting”) of Globus Medical, Inc. (the “Company”) was held on June 5, 2019. At the Annual Meeting, the stockholders voted on the following four proposals and cast their votes as described below.

Proposal 1

The individuals listed below were each elected at the Annual Meeting to serve a three-year term on the Company’s Board of Directors.

Proposal 2

Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019. This proposal was approved.

Proposal 3

A non-binding advisory vote to approve the compensation of the Company’s named executive officers, as described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission. This proposal was approved.

Proposal 4

A non-binding advisory vote on the preferred frequency of the advisory vote on the compensation of the Company’s named executive officers, as described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission. “1 Year” was approved.

(d) As disclosed above, the stockholders recommended holding an advisory vote on executive compensation every year. Consistent with the voting results, the Board of Directors (the “Board”) of the Company has determined that the Company will hold future advisory votes on executive compensation every year until the next required advisory vote on the frequency of stockholder advisory votes on executive compensation, which shall be no later than the Company’s annual meeting in 2025.